Literature DB >> 9658374

Role of immune serum globulins in pregnant women during an epidemic of hepatitis E.

V A Arankalle1, M S Chadha, B M Dama, S A Tsarev, R H Purcell, K Banerjee.   

Abstract

The efficacy of an Indian preparation of immune serum globulins (ISG) was evaluated among pregnant women during an epidemic of hepatitis E in Karad, Western India from January to March 1993. Ten of 55 women receiving ISG developed immunoglobulin M (IgM) antibodies to hepatitis E virus (anti-HEV) during the 1 month of follow-up compared with 18 out of 53 control subjects. Although the total number of recent HEV infections was significantly less in the ISG-treated group, no significant difference could be shown in the proportion of clinical hepatitis E cases because of the very small numbers of patients who developed clinical disease. The observed marginal beneficial effect of ISG might be the result of a low immunoglobulin G (IgG) anti-HEV IgG titre (1:500) of the ISG preparation used. Preparation and testing of high-titred ISG should be a high priority for protecting pregnant women during epidemics of hepatitis E.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9658374     DOI: 10.1046/j.1365-2893.1998.00096.x

Source DB:  PubMed          Journal:  J Viral Hepat        ISSN: 1352-0504            Impact factor:   3.728


  10 in total

1.  Hepatitis E: Epidemiology and prevention.

Authors:  Eyasu H Teshale; Dale J Hu
Journal:  World J Hepatol       Date:  2011-12-27

Review 2.  Hepatitis e and acute liver failure in pregnancy.

Authors:  Subrat K Acharya
Journal:  J Clin Exp Hepatol       Date:  2013-09-05

3.  Overview of Hepatitis E Virus.

Authors:  Susan Skidmore
Journal:  Curr Infect Dis Rep       Date:  2002-04       Impact factor: 3.725

4.  Hepatitis E in Damascus, Syria.

Authors:  J al-Azmeh; G Frösner; Z Darwish; H Bashour; F Monem
Journal:  Infection       Date:  1999 May-Jun       Impact factor: 3.553

Review 5.  Hepatitis E and pregnancy: understanding the pathogenesis.

Authors:  Udayakumar Navaneethan; Mayar Al Mohajer; Mohamed T Shata
Journal:  Liver Int       Date:  2008-07-25       Impact factor: 5.828

Review 6.  Hepatitis E vaccines: progress and prospects.

Authors:  Harald Claus Worm; Gerhard Wirnsberger
Journal:  Drugs       Date:  2004       Impact factor: 9.546

7.  Selective suppression of NF-kBp65 in hepatitis virus-infected pregnant women manifesting severe liver damage and high mortality.

Authors:  Bhupesh K Prusty; Suresh Hedau; Ajay Singh; Premasis Kar; Bhudev C Das
Journal:  Mol Med       Date:  2007 Sep-Oct       Impact factor: 6.354

Review 8.  Viral hepatitis vaccination during pregnancy.

Authors:  Yueyuan Zhao; Hui Jin; Xuefeng Zhang; Bei Wang; Pei Liu
Journal:  Hum Vaccin Immunother       Date:  2016-04-02       Impact factor: 3.452

9.  The expression patterns of immune response genes in the Peripheral Blood Mononuclear cells of pregnant women presenting with subclinical or clinical HEV infection are different and trimester-dependent: A whole transcriptome analysis.

Authors:  Ashwini Y Ramdasi; Vidya A Arankalle
Journal:  PLoS One       Date:  2020-02-03       Impact factor: 3.240

10.  Effect of pregnancy on anti-HEV antibody titres, plasma cytokines and the corresponding gene expression levels in the PBMCs of patients presenting with self-recovering clinical and subclinical hepatitis E.

Authors:  Ashwini Y Ramdasi; Ravi P Arya; Vidya A Arankalle
Journal:  PLoS One       Date:  2014-08-01       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.